BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Roberts EA, Schilsky ML; Division of Gastroenterology and Nutrition, Hospital for Sick Children, Toronto, Ontario, Canada. A practice guideline on Wilson disease. Hepatology. 2003;37:1475-1492. [PMID: 12774027 DOI: 10.1053/jhep.2003.50252] [Cited by in Crossref: 291] [Cited by in F6Publishing: 192] [Article Influence: 16.2] [Reference Citation Analysis]
Number Citing Articles
1 Kumar N, Butz JA, Burritt MF. Clinical significance of the laboratory determination of low serum copper in adults. Clinical Chemical Laboratory Medicine 2007;45. [DOI: 10.1515/cclm.2007.292] [Cited by in Crossref: 15] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
2 Müller T, Koppikar S, Taylor RM, Carragher F, Schlenck B, Heinz-Erian P, Kronenberg F, Ferenci P, Tanner S, Siebert U, Staudinger R, Mieli-Vergani G, Dhawan A. Re-evaluation of the penicillamine challenge test in the diagnosis of Wilson's disease in children. J Hepatol 2007;47:270-6. [PMID: 17449133 DOI: 10.1016/j.jhep.2007.03.011] [Cited by in Crossref: 66] [Cited by in F6Publishing: 43] [Article Influence: 4.7] [Reference Citation Analysis]
3 Guillaud O, Dumortier J, Sobesky R, Debray D, Wolf P, Vanlemmens C, Durand F, Calmus Y, Duvoux C, Dharancy S. Long term results of liver transplantation for Wilson’s disease: experience in France. J Hepatol. 2014;60:579-589. [PMID: 24211743 DOI: 10.1016/j.jhep.2013.10.025] [Cited by in Crossref: 62] [Cited by in F6Publishing: 43] [Article Influence: 7.8] [Reference Citation Analysis]
4 Weiss KH, Schäfer M, Gotthardt DN, Angerer A, Mogler C, Schirmacher P, Schemmer P, Stremmel W, Sauer P. Outcome and development of symptoms after orthotopic liver transplantation for Wilson disease. Clin Transplant. 2013;27:914-922. [PMID: 24118554 DOI: 10.1111/ctr.12259] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 4.5] [Reference Citation Analysis]
5 Pariente A. Comment traiter une première poussée d’ascite ? Gastroentérologie Clinique et Biologique 2004;28:256-65. [DOI: 10.1016/s0399-8320(04)95264-5] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
6 Wu F, Wang J, Pu C, Qiao L, Jiang C. Wilson's disease: a comprehensive review of the molecular mechanisms. Int J Mol Sci. 2015;16:6419-6431. [PMID: 25803104 DOI: 10.3390/ijms16036419] [Cited by in Crossref: 59] [Cited by in F6Publishing: 40] [Article Influence: 9.8] [Reference Citation Analysis]
7 Collins KL, Roberts EA, Adeli K, Bohn D, Harvey EA. Single pass albumin dialysis (SPAD) in fulminant Wilsonian liver failure: a case report. Pediatr Nephrol. 2008;23:1013-1016. [PMID: 18299897 DOI: 10.1007/s00467-008-0761-x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
8 Hessheimer AJ, Nacif L, Flores Villalba E, Fondevila C. Liver transplantation for acute liver failure. Cir Esp 2017;95:181-9. [PMID: 28433231 DOI: 10.1016/j.ciresp.2017.01.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Mageed SA, Rawla P, Mahmoud MA, Shahba A. Systemic lupus erythematosus, hypoparathyroidism, and hemolytic anemia in a patient with Wilson's disease. Reumatologia 2019;57:239-42. [PMID: 31548751 DOI: 10.5114/reum.2019.87622] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Murray KF, Carithers RL Jr;  AASLD. AASLD practice guidelines: Evaluation of the patient for liver transplantation. Hepatology. 2005;41:1407-1432. [PMID: 15880505 DOI: 10.1002/hep.20704] [Cited by in Crossref: 519] [Cited by in F6Publishing: 403] [Article Influence: 32.4] [Reference Citation Analysis]
11 Hayashi H, Wakusawa S, Yano M, Okada T. Genetic background of Japanese patients with adult-onset storage diseases in the liver. Hepatology Research 2007;37:777-83. [DOI: 10.1111/j.1872-034x.2007.00114.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Korman JD, Volenberg I, Balko J, Webster J, Schiodt FV, Squires RH Jr, Fontana RJ, Lee WM, Schilsky ML;  Pediatric and Adult Acute Liver Failure Study Groups. Screening for Wilson disease in acute liver failure: a comparison of currently available diagnostic tests. Hepatology. 2008;48:1167-1174. [PMID: 18798336 DOI: 10.1002/hep.22446] [Cited by in Crossref: 177] [Cited by in F6Publishing: 114] [Article Influence: 13.6] [Reference Citation Analysis]
13 Brown SA, Axenfeld E, Stonesifer EG, Hutson W, Hanish S, Raufman J, Urrunaga NH. Current and prospective therapies for acute liver failure. Disease-a-Month 2018;64:493-522. [DOI: 10.1016/j.disamonth.2018.04.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
14 Sorbello O, Sini M, Civolani A, Demelia L. HFE gene mutations and Wilson's disease in Sardinia. Dig Liver Dis 2010;42:216-9. [PMID: 19640812 DOI: 10.1016/j.dld.2009.06.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
15 Schwerdtle T, Hamann I, Jahnke G, Walter I, Richter C, Parsons JL, Dianov GL, Hartwig A. Impact of copper on the induction and repair of oxidative DNA damage, poly(ADP-ribosyl)ation and PARP-1 activity. Mol Nutr Food Res 2007;51:201-10. [PMID: 17230584 DOI: 10.1002/mnfr.200600107] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
16 Akyildiz BN, Yildirim S, Kondolot M, Arslan D. Is plasma exchange effective in prevention of hepatic transplantation in fulminant Wilson disease with hepatic failure? J Pediatr Gastroenterol Nutr. 2011;52:778-780. [PMID: 21593651 DOI: 10.1097/mpg.0b013e318208d0a3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
17 Perera VS, Liu H, Wang ZQ, Huang SD. Cell Permeable Au@ZnMoS4 Core-Shell Nanoparticles: Towards a Novel Cellular Copper Detoxifying Drug for Wilson's Disease. Chem Mater 2013;25:4703-9. [PMID: 25698847 DOI: 10.1021/cm402147u] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
18 Hay JE. Acute Liver Failure. Curr Treat Options Gastroenterol 2004;7:459-68. [PMID: 15527712 DOI: 10.1007/s11938-004-0005-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
19 Baldari S, Di Rocco G, Toietta G. Current Biomedical Use of Copper Chelation Therapy. Int J Mol Sci 2020;21:E1069. [PMID: 32041110 DOI: 10.3390/ijms21031069] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 17.0] [Reference Citation Analysis]
20 Bavdekar A. Therapeutic and management challenges in Wilson's disease. J Gastroenterol Hepatol 2004;19:S391-5. [DOI: 10.1111/j.1440-1746.2004.03709.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
21 Mak CM, Lam CW. Diagnosis of Wilson's disease: a comprehensive review. Crit Rev Clin Lab Sci 2008;45:263-90. [PMID: 18568852 DOI: 10.1080/10408360801991055] [Cited by in Crossref: 88] [Cited by in F6Publishing: 56] [Article Influence: 6.8] [Reference Citation Analysis]
22 Linn FH, Houwen RH, van Hattum J, van der Kleij S, van Erpecum KJ. Long-term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients. Hepatology. 2009;50:1442-1452. [PMID: 19731238 DOI: 10.1002/hep.23182] [Cited by in Crossref: 64] [Cited by in F6Publishing: 49] [Article Influence: 5.3] [Reference Citation Analysis]
23 Pfeiffer RF. Wilson Disease. Continuum (Minneap Minn). 2016;22:1246-1261. [PMID: 27495207 DOI: 10.1212/con.0000000000000350] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
24 Tanner S. A History of Wilson Disease. Clinical and Translational Perspectives on WILSON DISEASE. Elsevier; 2019. pp. 1-11. [DOI: 10.1016/b978-0-12-810532-0.00001-x] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Catana AM, Medici V. Liver transplantation for Wilson disease. World J Hepatol 2012; 4(1): 5-10 [PMID: 22312450 DOI: 10.4254/wjh.v4.i1.5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
26 Ichai P, Samuel D. Etiology and prognosis of fulminant hepatitis in adults. Liver Transpl. 2008;14 Suppl 2:S67-S79. [PMID: 18825677 DOI: 10.1002/lt.21612] [Cited by in Crossref: 126] [Cited by in F6Publishing: 93] [Article Influence: 10.5] [Reference Citation Analysis]
27 Jara Vega P, Hierro Llanillo L. [Wilson's disease: forms of presentation in childhood]. Gastroenterol Hepatol 2006;29:560-7. [PMID: 17129551 DOI: 10.1157/13094353] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
28 Marcellini M, Di Ciommo V, Callea F, Devito R, Comparcola D, Sartorelli MR, Carelli F, Nobili V. Treatment of Wilson’s disease with zinc from the time of diagnosis in pediatric patients: A single-hospital, 10-year follow-up study. Journal of Laboratory and Clinical Medicine 2005;145:139-43. [DOI: 10.1016/j.lab.2005.01.007] [Cited by in Crossref: 77] [Cited by in F6Publishing: 57] [Article Influence: 4.8] [Reference Citation Analysis]
29 Wiernicka A, Jańczyk W, Dądalski M, Avsar Y, Schmidt H, Socha P. Gastrointestinal side effects in children with Wilson's disease treated with zinc sulphate. World J Gastroenterol 2013; 19(27): 4356-4362 [PMID: 23885147 DOI: 10.3748/wjg.v19.i27.4356] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
30 Lech T, Sadlik JK. Contribution to the data on copper concentration in blood and urine in patients with Wilson's disease and in normal subjects. Biol Trace Elem Res 2007;118:16-20. [PMID: 17848726 DOI: 10.1007/s12011-007-0015-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
31 Li X, Lu Z, Lin Y, Lu X, Xu Y, Cheng J, Shao Y, Su X, Liu Z, Sheng H, Cai Y, Li T, Zhou Z, Tan J, Liu H, Huang Y, Liu L, Zeng C. Clinical features and mutational analysis in 114 young children with Wilson disease from South China. Am J Med Genet A 2019;179:1451-8. [PMID: 31172689 DOI: 10.1002/ajmg.a.61254] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Javaid S, Shah SGS, Chaudhary AJ, Khan MH. Assessment of Trace Metal Contamination of Drinking Water in the Pearl Valley, Azad Jammu and Kashmir. Clean Soil Air Water 2008;36:216-21. [DOI: 10.1002/clen.200700055] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
33 Li X, Zhang W, Zhou D, Lv T, Xu A, Wang H, Zhao X, Zhang B, Li Y, Jia S, Wang Y, Wang X, Wu Z, Duan W, Wang Q, Nan Y, Shang J, Jiang W, Chen Y, Zheng S, Liu M, Sun L, You H, Jia J, Ou X, Huang J. Complex ATP7B mutation patterns in Wilson disease and evaluation of a yeast model for functional analysis of variants. Hum Mutat 2019;40:552-65. [PMID: 30702195 DOI: 10.1002/humu.23714] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
34 Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML. Wilson’s disease. Lancet. 2007;369:397-408. [PMID: 17276780 DOI: 10.1016/s0140-6736(07)60196-2] [Cited by in Crossref: 660] [Cited by in F6Publishing: 194] [Article Influence: 47.1] [Reference Citation Analysis]
35 Medici V, Rossaro L, Sturniolo GC. Wilson disease--a practical approach to diagnosis, treatment and follow-up. Dig Liver Dis. 2007;39:601-609. [PMID: 17382611 DOI: 10.1016/j.dld.2006.12.095] [Cited by in Crossref: 55] [Cited by in F6Publishing: 41] [Article Influence: 3.9] [Reference Citation Analysis]
36 Polson J, Lee WM; American Association for the Study of Liver Disease. AASLD position paper: the management of acute liver failure. Hepatology. 2005;41:1179-1197. [PMID: 15841455 DOI: 10.1002/hep.20703] [Cited by in Crossref: 603] [Cited by in F6Publishing: 500] [Article Influence: 37.7] [Reference Citation Analysis]
37 Morisco F, Pagliaro L, Caporaso N, Bianco E, Sagliocca L, Fargion S, Smedile A, Salvagnini M, Mele A. Consensus recommendations for managing asymptomatic persistent non-virus non-alcohol related elevation of aminotransferase levels: suggestions for diagnostic procedures and monitoring. Dig Liver Dis. 2008;40:585-598. [PMID: 18395501 DOI: 10.1016/j.dld.2008.02.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
38 Koh C, Zhao X, Samala N, Sakiani S, Liang TJ, Talwalkar JA. AASLD clinical practice guidelines: a critical review of scientific evidence and evolving recommendations. Hepatology 2013;58:2142-52. [PMID: 23775835 DOI: 10.1002/hep.26578] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 4.9] [Reference Citation Analysis]
39 Liu J, Luan J, Zhou X, Cui Y, Han J. Epidemiology, diagnosis, and treatment of Wilson's disease. Intractable Rare Dis Res. 2017;6:249-255. [PMID: 29259852 DOI: 10.5582/irdr.2017.01057] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
40 Klein D, Arora U, Lichtmannegger J, Finckh M, Heinzmann U, Summer KH. Tetrathiomolybdate in the treatment of acute hepatitis in an animal model for Wilson disease. Journal of Hepatology 2004;40:409-16. [DOI: 10.1016/j.jhep.2003.11.034] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
41 Hachmöller O, Aichler M, Schwamborn K, Lutz L, Werner M, Sperling M, Walch A, Karst U. Element bioimaging of liver needle biopsy specimens from patients with Wilson’s disease by laser ablation-inductively coupled plasma-mass spectrometry. Journal of Trace Elements in Medicine and Biology 2016;35:97-102. [DOI: 10.1016/j.jtemb.2016.02.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
42 Paradisi I, De Freitas L, Arias S. Most frequent mutation c.3402delC (p.Ala1135GlnfsX13) among Wilson disease patients in Venezuela has a wide distribution and two old origins. Eur J Med Genet 2015;58:59-65. [PMID: 25497208 DOI: 10.1016/j.ejmg.2014.12.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
43 da Silva-Júnior FP, Carrasco AE, da Silva Mendes AM, Lopes AJ, Nobre E Souza MA, de Bruin VM. Swallowing dysfunction in Wilson's disease: a scintigraphic study. Neurogastroenterol Motil 2008;20:285-90. [PMID: 18036136 DOI: 10.1111/j.1365-2982.2007.01036.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
44 Pfeiffer RF. Wilson's disease. Handb Clin Neurol 2011;100:681-709. [PMID: 21496616 DOI: 10.1016/B978-0-444-52014-2.00049-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
45 Chappuis P, Callebert J, Quignon V, Woimant F, Laplanche JL. Late neurological presentations of Wilson disease patients in French population and identification of 8 novel mutations in the ATP7B gene. J Trace Elem Med Biol. 2007;21:37-42. [PMID: 17317524 DOI: 10.1016/j.jtemb.2006.11.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
46 Fox AN, Schilsky M. Once Daily Trientine for Maintenance Therapy of Wilson Disease. Am J Gastroenterology 2008;103:494-5. [DOI: 10.1111/j.1572-0241.2007.01646_15.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
47 Kapuria D, Strasser K, Qasem A. Diffuse large B-cell lymphoma causing acute liver failure: a rare case of survival. BMJ Case Rep 2015;2015:bcr2015209328. [PMID: 25969490 DOI: 10.1136/bcr-2015-209328] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
48 Hirschfield GM, Kumagi T, Heathcote EJ. Preventative hepatology: minimising symptoms and optimising care. Liver Int 2008;28:922-34. [PMID: 18783540 DOI: 10.1111/j.1478-3231.2008.01816.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
49 Cabras T, Sanna M, Manconi B, Fanni D, Demelia L, Sorbello O, Iavarone F, Castagnola M, Faa G, Messana I. Proteomic investigation of whole saliva in Wilson's disease. J Proteomics 2015;128:154-63. [PMID: 26254010 DOI: 10.1016/j.jprot.2015.07.033] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
50 Galosi S, Nardecchia F, Leuzzi V. Treatable Inherited Movement Disorders in Children: Spotlight on Clinical and Biochemical Features. Mov Disord Clin Pract 2020;7:154-66. [PMID: 32071932 DOI: 10.1002/mdc3.12897] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
51 Fontana RJ. Acute liver failure including acetaminophen overdose. Med Clin North Am. 2008;92:761-794, viii. [PMID: 18570942 DOI: 10.1016/j.mcna.2008.03.005] [Cited by in Crossref: 136] [Cited by in F6Publishing: 113] [Article Influence: 10.5] [Reference Citation Analysis]
52 Lech T, Hydzik P, Kosowski B. Significance of copper determination in late onset of Wilson's disease. Clin Toxicol (Phila) 2007;45:688-94. [PMID: 17849244 DOI: 10.1080/15563650701502535] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
53 Ala A, Schilsky ML. Wilson disease: pathophysiology, diagnosis, treatment, and screening. Clin Liver Dis. 2004;8:787-805. [PMID: 15464656 DOI: 10.1016/j.cld.2004.06.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
54 Merle U, Eisenbach C, Weiss KH, Tuma S, Stremmel W. Serum ceruloplasmin oxidase activity is a sensitive and highly specific diagnostic marker for Wilson’s disease. J Hepatol. 2009;51:925-930. [PMID: 19720421 DOI: 10.1016/j.jhep.2009.06.022] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
55 Schilsky ML. Non-invasive testing for Wilson disease: revisiting the d-penicillamine challenge test. J Hepatol 2007;47:172-3. [PMID: 17570556 DOI: 10.1016/j.jhep.2007.05.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
56 Kumar S, Thapa BR, Kaur G, Prasad R. Familial gene analysis for Wilson disease from north-west Indian patients. Ann Hum Biol 2006;33:177-86. [PMID: 16684691 DOI: 10.1080/03014460500503275] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
57 Zhang Y, Wang D, Wei W, Zeng X. Wilson's disease combined with systemic lupus erythematosus: a case report and literature review. BMC Neurol 2018;18:85. [PMID: 29907136 DOI: 10.1186/s12883-018-1085-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
58 Amano T, Matsubara T, Nishida T, Shimakoshi H, Shimoda A, Sugimoto A, Takahashi K, Mukai K, Yamamoto M, Hayashi S, Nakajima S, Fukui K, Inada M. Clinically diagnosed late-onset fulminant Wilson’s disease without cirrhosis: A case report. World J Gastroenterol 2018; 24(2): 290-296 [PMID: 29375214 DOI: 10.3748/wjg.v24.i2.290] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
59 Walshe JM. Hepatic Wilson's disease: initial treatment and long-term management. Curr Treat Options Gastroenterol 2005;8:467-72. [PMID: 16313864 DOI: 10.1007/s11938-005-0033-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
60 Hachmöller O, Aichler M, Schwamborn K, Lutz L, Werner M, Sperling M, Walch A, Karst U. Investigating the influence of standard staining procedures on the copper distribution and concentration in Wilson’s disease liver samples by laser ablation-inductively coupled plasma-mass spectrometry. Journal of Trace Elements in Medicine and Biology 2017;44:71-5. [DOI: 10.1016/j.jtemb.2017.06.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
61 Cho YH, Jeong DW, Lee SY, Park SK, Yoon KT, Kim YJ, Lee JK, Lee YH. A Case of Wilson's Disease in Patient with Mildly Elevated Liver Enzymes. Korean J Fam Med 2011;32:205-8. [PMID: 22745856 DOI: 10.4082/kjfm.2011.32.3.205] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
62 Firneisz G, Szonyi L, Ferenci P, Willheim C, Horvath A, Folhoffer A, Tulassay Z, Szalay F. The Other Mutation Is Found: Follow-Up of an Exceptional Family with Wilson Disease. Am J Gastroenterology 2004;99:2504-5. [DOI: 10.1111/j.1572-0241.2004.41389_8.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
63 Fairweather-Tait SJ, Harvey LJ, Collings R. Risk-benefit analysis of mineral intakes: case studies on copper and iron. Proc Nutr Soc 2011;70:1-9. [PMID: 20860861 DOI: 10.1017/S0029665110003873] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
64 Portala K, Waldenström E, von Knorring L, Westermark K. Psychopathology and personality traits in patients with treated Wilson disease grouped according to gene mutations. Upsala Journal of Medical Sciences 2009;113:79-94. [DOI: 10.3109/2000-1967-216] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
65 Petrasek J, Jirsa M, Sperl J, Kozak L, Taimr P, Spicak J, Filip K, Trunecka P. Revised King’s College score for liver transplantation in adult patients with Wilson’s disease. Liver Transpl. 2007;13:55-61. [PMID: 17154398 DOI: 10.1002/lt.20920] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
66 Ferenci P. Pathophysiology and clinical features of Wilson disease. Metab Brain Dis 2004;19:229-39. [PMID: 15554419 DOI: 10.1023/b:mebr.0000043973.10494.85] [Cited by in Crossref: 76] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
67 López de Romaña D, Olivares M, Uauy R, Araya M. Risiken und Nutzen von Kupfer im Licht neuer Erkenntnisse zur Kupferhomöostase. Perspectives in Medicine 2014;2:40-55. [DOI: 10.1016/j.permed.2013.09.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
68 El-Karaksy H, Fahmy M, El-Raziky MS, El-Hawary M, El-Sayed R, El-Koofy N, El-Mougy F, El-Hennawy A, El-Shabrawi M. A clinical study of Wilson's disease: The experience of a single Egyptian Paediatric Hepatology Unit. Arab J Gastroenterol 2011;12:125-30. [PMID: 22055589 DOI: 10.1016/j.ajg.2011.07.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
69 Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD;  American Association for the Study of Liver Diseases. Liver biopsy. Hepatology. 2009;49:1017-1044. [PMID: 19243014 DOI: 10.1002/hep.22742] [Cited by in Crossref: 1217] [Cited by in F6Publishing: 1014] [Article Influence: 101.4] [Reference Citation Analysis]
70 Leggio L, Ferrulli A, Mirijello A, Abenavoli L, Di Giuda D, Funiciello S, Rotoli M, Gasbarrini G, Addolorato G. Penicillamine-Related Lichenoid Dermatitis and Utility of Zinc Acetate in a Wilson Disease Patient with Hepatic Presentation, Anxiety and Spect Abnormalities. Int J Immunopathol Pharmacol 2007;20:185-90. [DOI: 10.1177/039463200702000122] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
71 Soltanzadeh A, Soltanzadeh P, Nafissi S, Ghorbani A, Sikaroodi H, Lotfi J. Wilson’s Disease: A Great Masquerader. Eur Neurol 2007;57:80-5. [DOI: 10.1159/000098056] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
72 Liggi M, Mais C, Demurtas M, Sorbello O, Demelia E, Civolani A, Demelia L. Uneven distribution of hepatic copper concentration and diagnostic value of double-sample biopsy in Wilson's disease. Scandinavian Journal of Gastroenterology 2013;48:1452-8. [DOI: 10.3109/00365521.2013.845904] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
73 Hayashi H, Hattori A, Tatsumi Y, Hayashi K, Katano Y, Ueyama J, Wakusawa S, Yano M, Goto H. Various copper and iron overload patterns in the livers of patients with Wilson disease and idiopathic copper toxicosis. Med Mol Morphol 2013;46:133-40. [DOI: 10.1007/s00795-013-0015-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
74 Merle U, Schaefer M, Ferenci P, Stremmel W. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut. 2007;56:115-120. [PMID: 16709660 DOI: 10.1002/hep.1840120526] [Cited by in Crossref: 152] [Cited by in F6Publishing: 127] [Article Influence: 10.1] [Reference Citation Analysis]
75 Bucuvalas J, Yazigi N, Squires RH. Acute Liver Failure in Children. Clinics in Liver Disease 2006;10:149-68. [DOI: 10.1016/j.cld.2005.10.006] [Cited by in Crossref: 43] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
76 Fung KT, Fung J, Lai CL, Yuen MF. Etiologies of chronic liver diseases in Hong Kong. Eur J Gastroenterol Hepatol. 2007;19:659-664. [PMID: 17625435 DOI: 10.1097/meg.0b013e3281ace0b7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
77 Iorio R, D???ambrosi M, Marcellini M, Barbera C, Maggiore G, Zancan L, Giacchino R, Vajro P, Marazzi MG, Francavilla R, Michielutti F, Resti M, Frediani T, Pastore M, Mazzarella G, Fusco G, Cirillo F. Serum Transaminases in Children with Wilson???s Disease: . Journal of Pediatric Gastroenterology and Nutrition 2004;39:331-6. [DOI: 10.1097/00005176-200410000-00006] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 2.5] [Reference Citation Analysis]
78 Jiménez G, Cambronero V, Morales C, Mora A, Guzmán C, Jiménez-rivera C. Enfermedad de Wilson: experiencia pediátrica en Costa Rica. Gastroenterología y Hepatología 2009;32:274-8. [DOI: 10.1016/j.gastrohep.2008.12.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
79 Huster D, Kühn H, Mössner J, Caca K. Morbus Wilson. Internist 2005;46:731-40. [DOI: 10.1007/s00108-005-1432-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
80 Merle U, Weiss KH, Eisenbach C, Tuma S, Ferenci P, Stremmel W. Truncating mutations in the Wilson disease gene ATP7B are associated with very low serum ceruloplasmin oxidase activity and an early onset of Wilson disease. BMC Gastroenterol 2010;10:8. [PMID: 20082719 DOI: 10.1186/1471-230X-10-8] [Cited by in Crossref: 58] [Cited by in F6Publishing: 25] [Article Influence: 5.3] [Reference Citation Analysis]
81 Roberts EA, Sarkar B. Liver as a key organ in the supply, storage, and excretion of copper. The American Journal of Clinical Nutrition 2008;88:851S-4S. [DOI: 10.1093/ajcn/88.3.851s] [Cited by in Crossref: 44] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
82 Lin J, Lin K, Wang H, Wong M. Psychological Presentations Without Hepatic Involvement in Wilson Disease. Pediatric Neurology 2006;35:284-6. [DOI: 10.1016/j.pediatrneurol.2006.04.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
83 Hoffmann G. Copper-Associated Liver Diseases. Veterinary Clinics of North America: Small Animal Practice 2009;39:489-511. [DOI: 10.1016/j.cvsm.2009.02.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
84 Weiss KH, Runz H, Noe B, Gotthardt DN, Merle U, Ferenci P, Stremmel W, Füllekrug J. Genetic analysis of BIRC4/XIAP as a putative modifier gene of Wilson disease. J Inherit Metab Dis 2010;33 Suppl 3:S233-40. [PMID: 20517649 DOI: 10.1007/s10545-010-9123-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
85 Arnon R, Annunziato R, Schilsky M, Miloh T, Willis A, Sturdevant M, Sakworawich A, Suchy F, Kerkar N. Liver transplantation for children with Wilson disease: comparison of outcomes between children and adults. Clin Transplant. 2011;25:E52-E60. [PMID: 20946468 DOI: 10.1111/j.1399-0012.2010.01327.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 44] [Article Influence: 5.4] [Reference Citation Analysis]
86 Tatsumi Y, Shinohara T, Imoto M, Wakusawa S, Yano M, Hayashi K, Hattori A, Hayashi H, Shimizu A, Ichiki T, Nakashima S, Katano Y, Goto H. Potential of the international scoring system for the diagnosis of Wilson disease to differentiate Japanese patients who need anti-copper treatment: Diagnosis of Wilson disease. Hepatology Research 2011;41:887-96. [DOI: 10.1111/j.1872-034x.2011.00835.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
87 Wang J, Lu Y, Wang X, Zhu Q. Urinary copper/zinc ratio: a promising parameter for replacement of 24-hour urinary copper excretion for diagnosis of Wilson’s disease in children. World J Pediatr 2010;6:148-53. [DOI: 10.1007/s12519-010-0023-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
88 Rao R, Shu S, Han YZ, Chiu YJ, Han YS. A case report: Co-occurrence of Wilson disease and oculocutaneous albinism in a Chinese patient. Medicine (Baltimore). 2018;97:e13744. [PMID: 30558096 DOI: 10.1097/md.0000000000013744] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
89 Ellingsen DG, Møller LB, Aaseth J. Copper. Handbook on the Toxicology of Metals. Elsevier; 2015. pp. 765-86. [DOI: 10.1016/b978-0-444-59453-2.00035-4] [Cited by in Crossref: 11] [Article Influence: 1.8] [Reference Citation Analysis]
90 Tan J, Surti B, Saab S. Pregnancy and cirrhosis. Liver Transpl. 2008;14:1081-1091. [PMID: 18668664 DOI: 10.1002/lt.21572] [Cited by in Crossref: 77] [Cited by in F6Publishing: 56] [Article Influence: 5.9] [Reference Citation Analysis]
91 Honma Y, Harada M, Sato M, Katsuki Y, Hiura M, Shibata M, Narita R, Harada R, Abe S, Tabaru A, Tajiri N, Shimajiri S. Late diagnosed Wilson disease with hepatic and neurological manifestations: Late diagnosed Wilson disease. Hepatology Research 2011;41:270-6. [DOI: 10.1111/j.1872-034x.2010.00754.x] [Cited by in Crossref: 7] [Article Influence: 0.7] [Reference Citation Analysis]
92 Zhou X, Xiao X, Li X, Qin H, Pu X, Chen D, Wu C, Feng L, Liang X. A study of susceptibility-weighted imaging in patients with Wilson disease during the treatment of metal chelator. J Neurol 2020;267:1643-50. [DOI: 10.1007/s00415-020-09746-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
93 Uhl P, Fricker G, Haberkorn U, Mier W. Current status in the therapy of liver diseases. Int J Mol Sci. 2014;15:7500-7512. [PMID: 24786290 DOI: 10.3390/ijms15057500] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
94 Bohrer D, do Nascimento PC, Ramirez AG, Mendonça JKA, De Carvalho LM, Pomblum SCG. Comparison of ultrafiltration and solid phase extraction for the separation of free and protein-bound serum copper for the Wilson's disease diagnosis. Clinica Chimica Acta 2004;345:113-21. [DOI: 10.1016/j.cccn.2004.03.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
95 Huster D, Weizenegger M, Kress S, Mössner J, Caca K. Rapid detection of mutations in Wilson disease gene ATP7B by DNA strip technology. Clin Chem Lab Med 2004;42:507-10. [PMID: 15202786 DOI: 10.1515/CCLM.2004.086] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
96 Huster D, Lutsenko S. Wilson disease: not just a copper disorder. Analysis of a Wilson disease model demonstrates the link between copper and lipid metabolism. Mol BioSyst 2007;3:816. [DOI: 10.1039/b711118p] [Cited by in Crossref: 65] [Cited by in F6Publishing: 57] [Article Influence: 4.6] [Reference Citation Analysis]
97 Kumar S, Thapa B, Kaur G, Prasad R. Analysis of most common mutations R778G, R778L, R778W, I1102T and H1069Q in Indian Wilson disease patients: correlation between genotype/phenotype/copper ATPase activity. Mol Cell Biochem 2007;294:1-10. [PMID: 17160357 DOI: 10.1007/s11010-005-9028-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
98 Jiang W, Liu L, Chang Q, Xing F, Ma Z, Fang Z, Zhou J, Fu L, Wang H, Huang X, Chen X, Li Y, Li S. Production of Wilson Disease Model Rabbits with Homology-Directed Precision Point Mutations in the ATP7B Gene Using the CRISPR/Cas9 System. Sci Rep 2018;8:1332. [PMID: 29358698 DOI: 10.1038/s41598-018-19774-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
99 Rustom N, Bost M, Cour-Andlauer F, Lachaux A, Brunet AS, Boillot O, Bordet F, Valla F, Richard N, Javouhey E. Effect of molecular adsorbents recirculating system treatment in children with acute liver failure caused by Wilson disease. J Pediatr Gastroenterol Nutr. 2014;58:160-164. [PMID: 24458219 DOI: 10.1097/mpg.0b013e3182a853a3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 2] [Article Influence: 4.2] [Reference Citation Analysis]
100 Kim JJ, Kim YS, Kumar V. Heavy metal toxicity: An update of chelating therapeutic strategies. J Trace Elem Med Biol 2019;54:226-31. [PMID: 31109617 DOI: 10.1016/j.jtemb.2019.05.003] [Cited by in Crossref: 96] [Cited by in F6Publishing: 61] [Article Influence: 48.0] [Reference Citation Analysis]
101 Brumbaugh D, Mack C. Conjugated Hyperbilirubinemia in Children. Pediatrics in Review 2012;33:291-302. [DOI: 10.1542/pir.33-7-291] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
102 Akpinar E, Akhan O. Liver imaging findings of Wilson's disease. Eur J Radiol 2007;61:25-32. [PMID: 17161572 DOI: 10.1016/j.ejrad.2006.11.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
103 Gomes A, Dedoussis GV. Geographic distribution of ATP7B mutations in Wilson disease. Ann Hum Biol 2016;43:1-8. [PMID: 26207595 DOI: 10.3109/03014460.2015.1051492] [Cited by in Crossref: 38] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
104 Dalvi A, Padmanaban M. Wilson's disease: etiology, diagnosis, and treatment. Dis Mon. 2014;60:450-459. [PMID: 25234178 DOI: 10.1016/j.disamonth.2014.07.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
105 Rajappa M, Goyal A, Kaur J. Inherited metabolic disorders involving the eye: a clinico-biochemical perspective. Eye (Lond) 2010;24:507-18. [PMID: 19798114 DOI: 10.1038/eye.2009.229] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
106 Kotalová R, Jirsa M, Vávrová V, Vrábelová-pouchlá S, Macek M. Wilson disease as a cause of liver injury in cystic fibrosis. Journal of Cystic Fibrosis 2009;8:63-5. [DOI: 10.1016/j.jcf.2008.09.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
107 Hsi G, Cullen LM, Macintyre G, Chen MM, Glerum DM, Cox DW. Sequence variation in the ATP-binding domain of the Wilson disease transporter, ATP7B, affects copper transport in a yeast model system. Hum Mutat 2008;29:491-501. [PMID: 18203200 DOI: 10.1002/humu.20674] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
108 Zimbrean PC, Schilsky ML. Psychiatric aspects of Wilson disease: a review. Gen Hosp Psychiatry. 2014;36:53-62. [PMID: 24120023 DOI: 10.1016/j.genhosppsych.2013.08.007] [Cited by in Crossref: 89] [Cited by in F6Publishing: 61] [Article Influence: 11.1] [Reference Citation Analysis]
109 Lorincz MT. Wilson disease and related copper disorders. Neurogenetics, Part I. Elsevier; 2018. pp. 279-92. [DOI: 10.1016/b978-0-444-63233-3.00018-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 7.3] [Reference Citation Analysis]
110 Ellingsen DG, Horn N, Aaseth J. Copper. Handbook on the Toxicology of Metals. Elsevier; 2007. pp. 529-46. [DOI: 10.1016/b978-012369413-3/50081-1] [Cited by in Crossref: 11] [Article Influence: 0.8] [Reference Citation Analysis]
111 Larson AM. Acute Liver Failure. Disease-a-Month 2008;54:457-85. [DOI: 10.1016/j.disamonth.2008.03.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
112 Aggarwal A, Aggarwal N, Nagral A, Jankharia G, Bhatt M. A novel Global Assessment Scale for Wilson's Disease (GAS for WD). Mov Disord 2009;24:509-18. [PMID: 19115420 DOI: 10.1002/mds.22231] [Cited by in Crossref: 58] [Cited by in F6Publishing: 48] [Article Influence: 4.8] [Reference Citation Analysis]
113 Takeyama Y, Yokoyama K, Takata K, Tanaka T, Sakurai K, Matsumoto T, Iwashita H, Ueda S, Hirano G, Hanano T, Nakane H, Morihara D, Nishizawa S, Yoshikane M, Anan A, Kakumitsu S, Kitamura Y, Sakamoto M, Irie M, Iwata K, Shakado S, Sohda T, Watanabe H, Hirose S, Hayashi H, Noritomi T, Yamashita Y, Sakisaka S. Clinical features of Wilson disease: Analysis of 10 cases. Hepatol Res 2010;40:1204-11. [PMID: 21040274 DOI: 10.1111/j.1872-034X.2010.00728.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
114 Boaru SG, Merle U, Uerlings R, Zimmermann A, Flechtenmacher C, Willheim C, Eder E, Ferenci P, Stremmel W, Weiskirchen R. Laser ablation inductively coupled plasma mass spectrometry imaging of metals in experimental and clinical Wilson's disease. J Cell Mol Med 2015;19:806-14. [PMID: 25704483 DOI: 10.1111/jcmm.12497] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
115 Sauer SW, Merle U, Opp S, Haas D, Hoffmann GF, Stremmel W, Okun JG. Severe dysfunction of respiratory chain and cholesterol metabolism in Atp7b(-/-) mice as a model for Wilson disease. Biochim Biophys Acta 2011;1812:1607-15. [PMID: 21920437 DOI: 10.1016/j.bbadis.2011.08.011] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
116 Camarata MA, Ala A, Coskun AK, Deng Y, Gonzalez-Peralta RP, Maciejewski KR, Patel A, Rubman S, To U, Tomlin R, Schilsky ML, Zimbrean PC. The Effect of Mental Health, Neurological Disease, and Liver Disease on Quality of Life in Patients With Wilson Disease. J Acad Consult Liaison Psychiatry 2021;62:528-37. [PMID: 34044196 DOI: 10.1016/j.jaclp.2021.04.004] [Reference Citation Analysis]
117 Ping CC, Hassan Y, Aziz NA, Ghazali R, Awaisu A. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine?zinc): a case of decompensated liver cirrhosis in Wilson's disease. J Clin Pharm Ther 2007;32:101-7. [DOI: 10.1111/j.1365-2710.2007.00794.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
118 Agarwal M, Saba L, Gupta SK, Johri AM, Khanna NN, Mavrogeni S, Laird JR, Pareek G, Miner M, Sfikakis PP, Protogerou A, Sharma AM, Viswanathan V, Kitas GD, Nicolaides A, Suri JS. Wilson disease tissue classification and characterization using seven artificial intelligence models embedded with 3D optimization paradigm on a weak training brain magnetic resonance imaging datasets: a supercomputer application. Med Biol Eng Comput 2021;59:511-33. [PMID: 33547549 DOI: 10.1007/s11517-021-02322-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
119 Tamura S, Sugawara Y, Kishi Y, Akamatsu N, Kaneko J, Makuuchi M. Living-related liver transplantation for Wilson's disease. Clin Transplant 2005;19:483-6. [DOI: 10.1111/j.1399-0012.2005.00371.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
120 Lauwens S, Costas-Rodríguez M, Delanghe J, Van Vlierberghe H, Vanhaecke F. Quantification and isotopic analysis of bulk and of exchangeable and ultrafiltrable serum copper in healthy and alcoholic cirrhosis subjects. Talanta 2018;189:332-8. [PMID: 30086927 DOI: 10.1016/j.talanta.2018.07.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
121 Areia M, Romãozinho JM, Ferreira M, Amaro P, Leitão MC. Fulminant hepatic failure: a Portuguese experience. Eur J Gastroenterol Hepatol 2007;19:665-9. [PMID: 17625436 DOI: 10.1097/MEG.0b013e3281ac20da] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
122 Chand PK, Murthy P. Mania as a presenting symptom of Wilson's disease. Acta Neuropsychiatr 2006;18:47-9. [DOI: 10.1111/j.0924-2708.2006.00108.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
123 Yoshitoshi EY, Takada Y, Oike F, Sakamoto S, Ogawa K, Kanazawa H, Ogura Y, Okamoto S, Haga H, Ueda M. Long-term outcomes for 32 cases of Wilson's disease after living-donor liver transplantation. Transplantation. 2009;87:261-267. [PMID: 19155982 DOI: 10.1097/tp.0b013e3181919984] [Cited by in Crossref: 52] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
124 Kim YB, Oh SH, Ko JS, Kim KM. Diagnostic accuracy of simple laboratory tests is not replicable in paediatric fulminant Wilson's disease. Liver Int 2021;41:1150-1. [PMID: 33861896 DOI: 10.1111/liv.14678] [Reference Citation Analysis]
125 Lankarani KB, Malek-Hosseini SA, Nikeghbalian S, Dehghani M, Pourhashemi M, Kazemi K, Janghorban P, Akbari M, Ghahramani S, Eghtesad B, Moini M, Rahmi Jaberi A, Shamsaifar A, Gholami S, Rahmanian F, Geramizadeh B. Fourteen Years of Experience of Liver Transplantation for Wilson's Disease; a Report on 107 Cases from Shiraz, Iran. PLoS One 2016;11:e0167890. [PMID: 27930723 DOI: 10.1371/journal.pone.0167890] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
126 Kleine RT, Mendes R, Pugliese R, Miura I, Danesi V, Porta G. Wilson's disease: an analysis of 28 Brazilian children. Clinics (Sao Paulo) 2012;67:231-5. [PMID: 22473403 DOI: 10.6061/clinics/2012(03)05] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
127 Caprai S, Loudianos G, Massei F, Gori L, Lovicu M, Maggiore G. Direct diagnosis of Wilson disease by molecular genetics. J Pediatr. 2006;148:138-140. [PMID: 16423615 DOI: 10.1016/j.jpeds.2005.07.036] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
128 Leggio L, Addolorato G, Abenavoli L, Gasbarrini G. Wilson's Disease: Clinical, Genetic and Pharmacological Findings. Int J Immunopathol Pharmacol 2005;18:7-14. [DOI: 10.1177/039463200501800102] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
129 Velez-pardo C, Rio MJD, Moreno S, Ramı́rez-gomez L, Correa G, Lopera F. New mutation (T1232P) of the ATP-7B gene associated with neurologic and neuropsychiatric dominance onset of Wilson’s disease in three unrelated Colombian kindred. Neuroscience Letters 2004;367:360-4. [DOI: 10.1016/j.neulet.2004.06.032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
130 Hanje AJ, Fortune B, Song M, Hill D, McClain C. The use of selected nutrition supplements and complementary and alternative medicine in liver disease. Nutr Clin Pract 2006;21:255-72. [PMID: 16772543 DOI: 10.1177/0115426506021003255] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
131 Wang LC, Wang JD, Tsai CR, Cheng SB, Lin CC. Clinical features and therapeutic response in Taiwanese children with Wilson’s disease: 12 years of experience in a single center. Pediatr Neonatol. 2010;51:124-129. [PMID: 20417464 DOI: 10.1016/s1875-9572(10)60022-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
132 Krumina A, Keiss J, Sondore V, Chernushenko A, Cernevska G, Zarina A, Micule I, Piekuse L, Kreile M, Lace B, Krumina Z, Rozentale B. From clinical and biochemical to molecular genetic diagnosis of Wilson disease in Latvia. Russ J Genet 2008;44:1195-200. [DOI: 10.1134/s1022795408100086] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
133 Chahine LM, Chemali ZN. The Bane of a Silent Illness: When Wilson's Disease Takes its Course. Int J Psychiatry Med 2006;36:333-8. [DOI: 10.2190/1a0b-2m98-0vve-485r] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
134 Hayashi H, Yano M, Fujita Y, Wakusawa S. Compound overload of copper and iron in patients with Wilson's disease. Med Mol Morphol 2006;39:121-6. [PMID: 16998622 DOI: 10.1007/s00795-006-0326-7] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
135 El-Shabrawi MH, Kamal NM. Medical management of chronic liver diseases in children (part I): focus on curable or potentially curable diseases. Paediatr Drugs 2011;13:357-70. [PMID: 21999649 DOI: 10.2165/11591610-000000000-00000] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
136 Poujois A, Woimant F. Challenges in the diagnosis of Wilson disease. Ann Transl Med 2019;7:S67. [PMID: 31179304 DOI: 10.21037/atm.2019.02.10] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
137 Oe S, Honma Y, Yabuki K, Morino K, Kumamoto K, Hayashi T, Kusanaga M, Ogino N, Minami S, Shibata M, Abe S, Harada M. Importance of a Liver Biopsy in the Management of Wilson Disease. Intern Med 2020;59:77-81. [PMID: 31511488 DOI: 10.2169/internalmedicine.3440-19] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
138 Bhidayasiri R. Differential diagnosis of common tremor syndromes. Postgrad Med J 2005;81:756-62. [PMID: 16344298 DOI: 10.1136/pgmj.2005.032979] [Cited by in Crossref: 79] [Cited by in F6Publishing: 41] [Article Influence: 5.3] [Reference Citation Analysis]
139 Harris MK, Shneyder N, Borazanci A, Korniychuk E, Kelley RE, Minagar A. Movement disorders. Med Clin North Am 2009;93:371-88, viii. [PMID: 19272514 DOI: 10.1016/j.mcna.2008.09.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
140 Ichai P, Samuel D. Epidemiology of liver failure. Clinics and Research in Hepatology and Gastroenterology 2011;35:610-7. [DOI: 10.1016/j.clinre.2011.03.010] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
141 Huang Y, Takatsuki M, Soyama A, Hidaka M, Ono S, Adachi T, Hara T, Okada S, Hamada T, Eguchi S. Living Donor Liver Transplantation for Wilson's Disease Associated with Fulminant Hepatic Failure: A Case Report. Am J Case Rep 2018;19:304-8. [PMID: 29549236 DOI: 10.12659/ajcr.907494] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
142 Sharma S, Toppo A, Rath B, Harbhajanka A, Lalita Jyotsna P. Hemolytic Anemia as a Presenting Feature of Wilson's Disease: A Case Report. Indian J Hematol Blood Transfus 2010;26:101-2. [PMID: 21886393 DOI: 10.1007/s12288-010-0034-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
143 Manolaki N, Nikolopoulou G, Daikos GL, Panagiotakaki E, Tzetis M, Roma E, Kanavakis E, Syriopoulou VP. Wilson disease in children: analysis of 57 cases. J Pediatr Gastroenterol Nutr. 2009;48:72-77. [PMID: 19172127 DOI: 10.1097/mpg.0b013e31817d80b8] [Cited by in Crossref: 48] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
144 Chanprasert S, Scaglia F. Adult liver disorders caused by inborn errors of metabolism: review and update. Mol Genet Metab 2015;114:1-10. [PMID: 25467056 DOI: 10.1016/j.ymgme.2014.10.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
145 Ferenci P. Review article: diagnosis and current therapy of Wilson's disease. Aliment Pharmacol Ther. 2004;19:157-165. [PMID: 14723607 DOI: 10.1046/j.1365-2036.2003.01813.x] [Cited by in Crossref: 102] [Cited by in F6Publishing: 74] [Article Influence: 6.0] [Reference Citation Analysis]
146 Arnon R, Calderon JF, Schilsky M, Emre S, Shneider BL. Wilson disease in children: serum aminotransferases and urinary copper on triethylene tetramine dihydrochloride (trientine) treatment. J Pediatr Gastroenterol Nutr. 2007;44:596-602. [PMID: 17460493 DOI: 10.1097/mpg.0b013e3180467715] [Cited by in Crossref: 43] [Cited by in F6Publishing: 11] [Article Influence: 3.1] [Reference Citation Analysis]
147 Merle U, Schaefer M, Ferenci P, Stremmel W. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut. 2007;56:115-120. [PMID: 16709660 DOI: 10.1136/gut.2005.087262] [Cited by in Crossref: 325] [Cited by in F6Publishing: 246] [Article Influence: 21.7] [Reference Citation Analysis]
148 Perera VS, Wickramaratne NP, Jaroniec M, Huang SD. A Highly Efficient and Extremely Selective Intracellular Copper Detoxifying Agent Based on Nanoparticles of ZnMoS4. J Mater Chem B 2014;2:257-61. [PMID: 25821583 DOI: 10.1039/C3TB20962H] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
149 Lo Curto AG, Marchi A, Grasso M, Arbustini E, Loudianos G, Brega A. Early Diagnosis of Wilson Disease in a Six-year-old Child. The Journal of Pediatrics 2006;148:141. [DOI: 10.1016/j.jpeds.2005.07.040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
150 Kitzberger R, Madl C, Ferenci P. Wilson Disease. Metab Brain Dis 2005;20:295-302. [DOI: 10.1007/s11011-005-7910-8] [Cited by in Crossref: 65] [Cited by in F6Publishing: 49] [Article Influence: 4.1] [Reference Citation Analysis]
151 Malakouti M, Kataria A, Ali SK, Schenker S. Elevated Liver Enzymes in Asymptomatic Patients - What Should I Do? J Clin Transl Hepatol 2017;5:394-403. [PMID: 29226106 DOI: 10.14218/JCTH.2017.00027] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
152 Timoshnikov VA, Kobzeva T, Selyutina OY, Polyakov NE, Kontoghiorghes GJ. Effective inhibition of copper-catalyzed production of hydroxyl radicals by deferiprone. J Biol Inorg Chem 2019;24:331-41. [DOI: 10.1007/s00775-019-01650-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
153 Poggio PD, Mazzoleni M. Screening in liver disease. World J Gastroenterol 2006; 12(33): 5272-5280 [PMID: 16981254 DOI: 10.3748/wjg.v12.i33.5272] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
154 Gitlin JD. Wilson disease. Gastroenterology. 2003;125:1868-1877. [PMID: 14724838 DOI: 10.1053/j.gastro.2003.05.010] [Cited by in Crossref: 263] [Cited by in F6Publishing: 227] [Article Influence: 15.5] [Reference Citation Analysis]
155 Mastoi GM, Shah SG, Khuhawar MY. Assessment of water quality of Manchar Lake in Sindh (Pakistan). Environ Monit Assess 2008;141:287-96. [PMID: 17929187 DOI: 10.1007/s10661-007-9895-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
156 Cassis L, Cortès-Saladelafont E, Molero-Luis M, Yubero D, González MJ, Ormazábal A, Fons C, Jou C, Sierra C, Castejon Ponce E, Ramos F, Armstrong J, O'Callaghan MM, Casado M, Montero R, Meavilla-Olivas S, Artuch R, Barić I, Bartoloni F, Bellettato CM, Bonifazi F, Ceci A, Cvitanović-Šojat L, Dali CI, D'Avanzo F, Fumic K, Giannuzzi V, Lampe C, Scarpa M, Garcia-Cazorla Á. Review and evaluation of the methodological quality of the existing guidelines and recommendations for inherited neurometabolic disorders. Orphanet J Rare Dis 2015;10:164. [PMID: 26714856 DOI: 10.1186/s13023-015-0376-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
157 Levy E, Brunet S, Alvarez F, Seidman E, Bouchard G, Escobar E, Martin S. Abnormal hepatobiliary and circulating lipid metabolism in the Long-Evans Cinnamon rat model of Wilson's disease. Life Sci 2007;80:1472-83. [PMID: 17303181 DOI: 10.1016/j.lfs.2007.01.017] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
158 Xuan A, Bookman I, Cox DW, Heathcote J. Three atypical cases of Wilson disease: Assessment of the Leipzig scoring system in making a diagnosis. Journal of Hepatology 2007;47:428-33. [DOI: 10.1016/j.jhep.2007.05.016] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
159 Kenney SM, Cox DW. Sequence variation database for the Wilson disease copper transporter, ATP7B. Hum Mutat 2007;28:1171-7. [PMID: 17680703 DOI: 10.1002/humu.20586] [Cited by in Crossref: 78] [Cited by in F6Publishing: 64] [Article Influence: 6.0] [Reference Citation Analysis]
160 Cheng F, Li G, Zhang F, Li X, Sun B, Kong L, Pu L, Wang K, Qian X, You W, Wang X. Outcomes of Living-Related Liver Transplantation for Wilson’s Disease: A Single-Center Experience in China. Transplantation 2009;87:751-7. [DOI: 10.1097/tp.0b013e318198a46e] [Cited by in Crossref: 34] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
161 Gouider-Khouja N. Wilson's disease. Parkinsonism Relat Disord 2009;15 Suppl 3:S126-9. [PMID: 20082972 DOI: 10.1016/S1353-8020(09)70798-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
162 Xie JJ, Wu ZY. Wilson's Disease in China. Neurosci Bull. 2017;33:323-330. [PMID: 28265897 DOI: 10.1007/s12264-017-0107-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
163 Woimant F, Poujois A, Bloch A, Jordi T, Laplanche JL, Morel H, Collet C. A novel deep intronic variant in ATP7B in five unrelated families affected by Wilson disease. Mol Genet Genomic Med 2020;8:e1428. [PMID: 32770663 DOI: 10.1002/mgg3.1428] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
164 Tisato F, Marzano C, Porchia M, Pellei M, Santini C. Copper in diseases and treatments, and copper-based anticancer strategies. Med Res Rev 2010;30:708-49. [PMID: 19626597 DOI: 10.1002/med.20174] [Cited by in Crossref: 71] [Cited by in F6Publishing: 100] [Article Influence: 6.5] [Reference Citation Analysis]
165 Davies LP, Macintyre G, Cox DW. New mutations in the Wilson disease gene, ATP7B: implications for molecular testing. Genet Test 2008;12:139-45. [PMID: 18373411 DOI: 10.1089/gte.2007.0072] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
166 Iorio R, D'Ambrosi M, Marcellini M, Barbera C, Maggiore G, Zancan L, Giacchino R, Vajro P, Marazzi MG, Francavilla R, Michielutti F, Resti M, Frediani T, Pastore M, Vegnente A. Persistence of elevated aminotransferases in Wilson's disease despite adequate therapy. Hepatology 2004;39:1173-4. [PMID: 15057922 DOI: 10.1002/hep.20165] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
167 Sakaida I, Kawaguchi K, Kimura T, Tamura F, Okita K. D-Penicillamine improved laparoscopic and histological findings of the liver in a patient with Wilson’s disease: 3-year follow-up after diagnosis of Coombs-negative hemolytic anemia of Wilson’s disease. J Gastroenterol 2005;40:646-51. [DOI: 10.1007/s00535-005-1600-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
168 Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. CMAJ 2005;172:367-79. [PMID: 15684121 DOI: 10.1503/cmaj.1040752] [Cited by in Crossref: 776] [Cited by in F6Publishing: 640] [Article Influence: 48.5] [Reference Citation Analysis]
169 Nicastro E, Loudianos G, Zancan L, D’Antiga L, Maggiore G, Marcellini M, Barbera C, Marazzi MG, Francavilla R, Pastore M. Genotype-phenotype correlation in Italian children with Wilson’s disease. J Hepatol. 2009;50:555-561. [PMID: 19118915 DOI: 10.1016/j.jhep.2008.09.020] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 3.5] [Reference Citation Analysis]
170 Motonishi S, Hayashi H, Fujita Y, Okada H, Kusakabe A, Ito M, Miyamoto K, Ueno T. Copper- and Iron-rich Matrices in Hepatocellular Lipofuscin Particles of a Young Male Patient: Diagnostic Ultrastructures for Wilson Disease. Ultrastructural Pathology 2009;30:409-14. [DOI: 10.1080/01913120600854327] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
171 Lorincz MT. Neurologic Wilson's disease. Ann N Y Acad Sci 2010;1184:173-87. [PMID: 20146697 DOI: 10.1111/j.1749-6632.2009.05109.x] [Cited by in Crossref: 180] [Cited by in F6Publishing: 116] [Article Influence: 16.4] [Reference Citation Analysis]
172 Mattová J, Poučková P, Kučka J, Skodová M, Vetrík M, Stěpánek P, Urbánek P, Petřík M, Nový Z, Hrubý M. Chelating polymeric beads as potential therapeutics for Wilson's disease. Eur J Pharm Sci 2014;62:1-7. [PMID: 24815561 DOI: 10.1016/j.ejps.2014.05.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
173 Eisenbach C, Sieg O, Stremmel W, Encke J, Merle U. Diagnostic criteria for acute liver failure due to Wilson disease. World J Gastroenterol 2007; 13(11): 1711-1714 [PMID: 17461475 DOI: 10.3748/wjg.v13.i11.1711] [Cited by in CrossRef: 57] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
174 Kelly C, Pericleous M. Wilson disease: more than meets the eye. Postgrad Med J 2018;94:335-47. [PMID: 29449431 DOI: 10.1136/postgradmedj-2017-135381] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
175 de Romaña DL, Olivares M, Uauy R, Araya M. Risks and benefits of copper in light of new insights of copper homeostasis. Journal of Trace Elements in Medicine and Biology 2011;25:3-13. [DOI: 10.1016/j.jtemb.2010.11.004] [Cited by in Crossref: 150] [Cited by in F6Publishing: 120] [Article Influence: 15.0] [Reference Citation Analysis]
176 Foruny JR, Boixeda D, López-Sanroman A, Vázquez-Sequeiros E, Villafruela M, Vázquez-Romero M, Rodríguez-Gandía M, de Argila CM, Camarero C, Milicua JM. Usefulness of penicillamine-stimulated urinary copper excretion in the diagnosis of adult Wilson's disease. Scand J Gastroenterol 2008;43:597-603. [PMID: 18415754 DOI: 10.1080/00365520701847044] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
177 Sauer V, Siaj R, Stöppeler S, Bahde R, Spiegel HU, Köhler G, Zibert A, Schmidt HH. Repeated transplantation of hepatocytes prevents fulminant hepatitis in a rat model of Wilson's disease. Liver Transpl. 2012;18:248-259. [PMID: 22140056 DOI: 10.1002/lt.22466] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
178 Mehta AR, Salaru G, Harrison JS. Stomatocytosis heralding a case of acute Wilsonian crisis. Ann Hematol 2010;89:527-9. [DOI: 10.1007/s00277-009-0832-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
179 Medici V, Trevisan CP, D’Incà R, Barollo M, Zancan L, Fagiuoli S, Martines D, Irato P, Sturniolo GC. Diagnosis and management of Wilson’s disease: results of a single center experience. J Clin Gastroenterol. 2006;40:936-941. [PMID: 17063115 DOI: 10.1097/01.mcg.0000225670.91722.59] [Cited by in Crossref: 78] [Cited by in F6Publishing: 73] [Article Influence: 5.6] [Reference Citation Analysis]
180 Dib N, Valsesia E, Malinge MC, Mauras Y, Misrahi M, Cal??s P. Late onset of Wilson??s disease in a family with genetic haemochromatosis: . European Journal of Gastroenterology & Hepatology 2006;18:43-7. [DOI: 10.1097/00042737-200601000-00008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
181 Woimant F, Chaine P, Favrole P, Mikol J, Chappuis P. La maladie de Wilson. Revue Neurologique 2006;162:773-81. [DOI: 10.1016/s0035-3787(06)75080-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
182 Sturm E, Piersma FE, Tanner MS, Socha P, Roberts EA, Shneider BL. Controversies and Variation in Diagnosing and Treating Children With Wilson Disease: Results of an International Survey. Journal of Pediatric Gastroenterology & Nutrition 2016;63:82-7. [DOI: 10.1097/mpg.0000000000001102] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 3.2] [Reference Citation Analysis]
183 Baki G, Bajdik J, Pintye-hódi K. Evaluation of powder mixtures and hydrophilic gastroretentive drug delivery systems containing zinc acetate and sodium bicarbonate. Journal of Pharmaceutical and Biomedical Analysis 2011;54:711-6. [DOI: 10.1016/j.jpba.2010.10.026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
184 Elleuch N, Feki I, Turki E, Miladi M, Boukhris A, Damak M, Mhiri C, Chappuis E, Woimant F. Nouvelle mutation du gène ATP7B responsable d’une maladie de Wilson avec atteinte neurologique sévère. Revue Neurologique 2010;166:550-2. [DOI: 10.1016/j.neurol.2009.10.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
185 Bretherick AD, Craig DG, Masterton G, Bates C, Davidson J, Martin K, Iredale JP, Simpson KJ. Acute liver failure in Scotland between 1992 and 2009; incidence, aetiology and outcome. QJM 2011;104:945-56. [PMID: 21729878 DOI: 10.1093/qjmed/hcr098] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
186 Mihaylova V, Todorov T, Jelev H, Cherninkova S, Raycheva M, Savov A, Kremensky I, Tournev I. Wilson’s disease in two consecutive generations in a Bulgarian Roma family. J Neurol 2007;254:1462-3. [DOI: 10.1007/s00415-007-0564-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
187 Altunay N, Gürkan R, Orhan U. A new ultrasonic-assisted cloud-point-extraction procedure for pre-concentration and determination of ultra-trace levels of copper in selected beverages and foods by flame atomic absorption spectrometry. Food Additives & Contaminants: Part A 2015;32:1475-87. [DOI: 10.1080/19440049.2015.1067725] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
188 Leinweber B, Möller JC, Scherag A, Reuner U, Günther P, Lang CJ, Schmidt HH, Schrader C, Bandmann O, Czlonkowska A, Oertel WH, Hefter H. Evaluation of the Unified Wilson's Disease Rating Scale (UWDRS) in German patients with treated Wilson's disease. Mov Disord 2008;23:54-62. [PMID: 17960799 DOI: 10.1002/mds.21761] [Cited by in Crossref: 64] [Cited by in F6Publishing: 51] [Article Influence: 4.9] [Reference Citation Analysis]
189 Folhoffer A, Ferenci P, Csak T, Horvath A, Hegedus D, Firneisz G, Osztovits J, Kosa JP, Willheim-Polli C, Szonyi L. Novel mutations of the ATP7B gene among 109 Hungarian patients with Wilson's disease. Eur J Gastroenterol Hepatol. 2007;19:105-111. [PMID: 17272994 DOI: 10.1097/01.meg.0000223904.70492.0b] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
190 Hessheimer AJ, Forner A, Varela M, Bruix J. Metabolic risk factors are a major comorbidity in patients with cirrhosis independent of the presence of hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2010;22:1239-1244. [PMID: 20505515 DOI: 10.1097/meg.0b013e32833aa19b] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
191 Kwo PY, Cohen SM, Lim JK. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. Am J Gastroenterol 2017;112:18-35. [PMID: 27995906 DOI: 10.1038/ajg.2016.517] [Cited by in Crossref: 300] [Cited by in F6Publishing: 235] [Article Influence: 60.0] [Reference Citation Analysis]
192 Russo MW. Current concepts in the evaluation of patients for liver transplantation. Expert Review of Gastroenterology & Hepatology 2014;1:307-20. [DOI: 10.1586/17474124.1.2.307] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]